SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689375-23-000055
Filing Date
2023-08-08
Accepted
2023-08-08 07:14:05
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q trda-20230630.htm   iXBRL 10-Q 1525290
2 EX-31.1 trda-20230630x10qex311.htm EX-31.1 10877
3 EX-32.1 trda-20230630x10qex312.htm EX-32.1 10886
4 EX-32.2 trda-20230630x10qex321.htm EX-32.2 7231
  Complete submission text file 0001689375-23-000055.txt   6004851

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20230630.xsd EX-101.SCH 36872
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trda-20230630_cal.xml EX-101.CAL 63527
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trda-20230630_def.xml EX-101.DEF 167138
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20230630_lab.xml EX-101.LAB 498500
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20230630_pre.xml EX-101.PRE 327061
65 EXTRACTED XBRL INSTANCE DOCUMENT trda-20230630_htm.xml XML 711759
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40969 | Film No.: 231149293
SIC: 2834 Pharmaceutical Preparations